Accuray (ARAY) Share-based Compensation (2010 - 2026)
Accuray's (ARAY) quarterly Share-based Compensation came in at $1.4 million in Q1 2026, down 81.32% year-on-year from $7.4 million in Q1 2025, and up 56.53% quarter-over-quarter from $881000.0 in Q4 2025.
Accuray (ARAY) Share-based Compensation (2010 - 2026) Analysis & Trends
Accuray's Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 81.32% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $12.2 million, a 37.52% decrease from a year earlier, with the FY2025 full-year figure at $200000.0, down 97.89% from the prior year.
- Share-based Compensation climbed to $1.4 million in Q1 2026 per ARAY's latest filing, from $881000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.6 million in Q1 2023 and bottomed at $200000.0 in Q2 2025.
- The 5-year median for Share-based Compensation is $2.4 million (2023), against an average of $3.0 million.
- Across the five-year window, Share-based Compensation surged 181.52% in 2023 and slumped 81.32% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $3.1 million in 2022, then slipped by 25.98% to $2.3 million in 2023, then retreated by 1.3% to $2.3 million in 2024, then sank by 61.43% to $881000.0 in 2025, then jumped by 56.53% to $1.4 million in 2026.
- Per Business Quant, the three latest ARAY Share-based Compensation figures stand at $1.4 million (Q1 2026), $881000.0 (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Accuray | 28,254.30 | -38.51 Mn | 25.29 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 881,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 7.38 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 7.44 Mn |
| Mar 31, 2024 | 7.44 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Dec 31, 2023 | 2.31 Mn |